acquisition
Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics
August 2, 2016Manufacturing and Production, Research and Development Pfizer, acquisition, bamboo therapeutics, gene therapy
Pfizer has announced that it has acquired gene therapy biotech Bamboo Therapeutics for an initial $150 million, with potential milestone …
China’s Fosun seals $1.3 billion deal for Gland Pharma
July 29, 2016Medical Communications, Sales and Marketing acquisition, fosun, gland, takeover
Fosun Pharmaceutical has agreed a deal to purchase an 86.1% stake of Gland Pharma, which will see the Chinese firm …
Shire adds to gastrointestinal portfolio with Pfizer compound acquisition
June 14, 2016Research and Development, Sales and Marketing Pfizer, Shire, acquisition, compound
Shire (LSE: SHP) has announced that it has acquired an investigational biologic for the treatment inflammatory bowel disease from Pfizer …
Jazz Pharmaceuticals to acquire Celator in $1.5 billion deal
May 31, 2016Manufacturing and Production, Sales and Marketing $1.5 billion, Vyxeos, acquisition, celator, jazz, leukaemia, merger, oncology
Jazz Pharmaceuticals (NASDAQ: JAZZ) has announced that it has entered into a definitive merger agreement with Celator Pharmaceuticals (NASDAQ: CPXX) …
Pfizer to acquire Anacor in $5.2 billion deal
May 16, 2016Manufacturing and Production, Sales and Marketing 5.2 billion, FDA, Pfizer, acquisition, anacor, crisaborole, merger
Pfizer (NYSE: PFE) has acquired Anacor Pharmaceuticals (NASDAQ: ANAC) in a deal worth around $5.2 billion, or $99.25 per share. …
AbbVie expands oncology portfolio with $5.8 billion Stemcentrx acquisition
April 29, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, acquisition, rova-t, stremcentrx, takeover
AbbVie (NYSE: ABBV) has announced the acquisition of Stemcentrx, and its lead late stage, lung cancer candidate Rova-T (rovalpituzumab tesirine), …
Abbott to purchase St Jude Medical in $25 billion deal
April 28, 2016Manufacturing and Production, Research and Development, Sales and Marketing $25, 25 billion, Abbott, Medical device, acquisition, purchase, st jude medical
Abbott (NYSE: ABT) has announced an agreement to purchase device manufacturer, St Jude Medical, in a deal worth $25 billion. …
Eisai announces agreement to set up new gastrointestinal speciality company
March 30, 2016Manufacturing and Production, Research and Development, Sales and Marketing Ajinomoto, Eisai, absorption, acquisition, ea pharma, gastrointestinal, merger, speciality
Eisai (TYO: 4523) and Ajinomoto Co. (TYO: 2802) have announced an agreement to establish a new gastrointestinal speciality pharmaceutical company, …
Lupin completes acquisition of US-based Gavis Pharmaceuticals
March 10, 2016Research and Development, Sales and Marketing FDA, Gavis, Lupin, acquisition, generics
Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …
Reports: $32bn Shire takeover of Baxalta close to done deal
January 4, 2016Sales and Marketing Baxalta, Shire, acquisition, merger
The deal may have failed to get over the line in 2015, but reports suggest the mega merger is to …
Mirror. Signal. Merger. How to deal with a pharma takeover
December 14, 2015Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers
So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …
Bristol-Myers Squibb enters academic R&D tie-up
November 4, 2015Research and Development BMS, Bristol-Myers Squibb, Cardioxy, John Hopkins, acquisition, immunooncology, job losses
Bristol-Myers Squibb and The Johns Hopkins University have entered into a collaboration agreement, as part of the pharma firm’s rare …
GSK ploughs $95m into research institute
June 17, 2015Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover
GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …
PrimeVigilance and Sound Opinion join forces
May 26, 2015acquisition, medical information, primevigilance
Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …
Pfizer to buy Hospira for $17 billion
February 5, 2015Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger
Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …
Latest content
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
